Approval lapsed) RoActemra tocilizumab 200 mg/ 10mL concentrate for solution for infusion (Roche Germany) | Therapeutic Goods Administration (TGA)
Roche | Actemra/RoActemra (tocilizumab)
Tocilizumab Injection Supply: Delhi HC asks Centre to hold meeting with Roche to ensure immediate supply of Tocilizumab - The Economic Times
Notfallzulassung für Tocilizumab bei Covid-19
Genentech's arthritis drug tocilizumab shows promise in Covid-19 trial
CHMP backs expanded approval of tocilizumab | MDedge Hematology and Oncology
Tocilizumab: Rheumamedikament senkt Corona-Sterblichkeit - WELT
Roche arthritis drug cuts deaths in hospitalized COVID-19 patients, study suggests | CBC News
Tocilizumab als Therapie bei schwerer COVID-19 zugelassen
Delhi HC Issues Order on Tocilizumab Shortage, Seeks Patent Working Information from Roche – SpicyIP
Tocilizumab bei schwerem Covid-19 zugelassen
Roche: Priority Review für Actemra/RoActemra | APOTHEKE ADHOC
RoACTEMRA®
Primärer Endpunkt verfehlt: COVID-19: Tocilizumab scheitert in Phase III
FDA approves drug to treat CRS induced by CAR T-cell therapy | MDedge Hematology and Oncology
Rote-Hand-Brief zu RoActemra® (Tocilizumab)
Tocilizumab erhält Zulassungsempfehlung | Gelbe Liste
/cloudfront-us-east-2.images.arcpublishing.com/reuters/QFWUTH5BLZN5LGWVT27LGWPZBE.jpg "Roche arthritis drug reduces COVID-19 deaths in trial in hospitalised patients | Reuters")
Roche arthritis drug reduces COVID-19 deaths in trial in hospitalised patients | Reuters
Tocilizumab erhält Zulassungsempfehlung | Gelbe Liste
Actemra Tocilizumab Injection at Rs 42900/box | Itolizumab Alzumab in Thane | ID: 23486802773
USTC Global on X: "The mechanism of using Tocilizumab to cure severe patients of COVID-19. @NIH @CDC @DrAiLynTan #coronavirus #COVID19 #CoronavirusOutbreak #coronaviruskorea #ItalyCoronavirus #italylockdown #IranCoVidTruth #Tocilizumab https://t.co ...
Patientenbroschüre für Erwachsene
Roche | Actemra
Health System News Teamwork Tackles Tocilizumab
